
1. j virol. 2001 nov;75(22):11079-87.

replication-competent attenuated, nonpropagating vesicular stomatitis viruses 
expressing respiratory syncytial virus (rsv) antigens protect mice rsv
challenge.

kahn js(1), roberts a, weibel c, buonocore l, rose jk.

author information: 
(1)department pediatrics, division infectious diseases, yale university
school medicine, new haven, connecticut 06520, usa. jeffrey.kahn@yale.edu

foreign glycoproteins expressed recombinant vesicular stomatitis virus (vsv)
can elicit specific protective immunity mouse model. have
previously demonstrated expression respiratory syncytial virus (rsv) g
(attachment) f (fusion) glycoprotein genes recombinant vsv. study,
we demonstrate expression rsv f g glycoproteins attenuated,
nonpropagating vsvs lack vsv g gene (vsvdeltag) incorporation
of rsv proteins recombinant virions. also show intranasal
vaccination mice nondefective vsv recombinants expressing rsv g (vsv-rsv 
g) rsv f (vsv-rsv f) elicited rsv-specific antibodies serum (by
enzyme-linked immunosorbent assay [elisa]) well neutralizing antibodies 
rsv afford complete protection rsv challenge. contrast,
vsvdeltag-rsv f induced detectable serum antibodies rsv elisa, no
detectable neutralizing antibodies, yet still protected rsv challenge.
vsvdeltag-rsv g failed induce detectable serum (by elisa) neutralizing 
antibodies failed protect rsv challenge. attenuated,
nonpropagating vsvdeltag-rsv f particularly attractive candidate live 
attenuated recombinant rsv vaccine.

doi: 10.1128/jvi.75.22.11079-11087.2001 
pmcid: pmc114687
pmid: 11602747  [indexed medline]

